A5045789717- Liver Disease Diagnosis and Treatment
- Hepatitis C virus research
- Renal Transplantation Outcomes and Treatments
- Liver Disease and Transplantation
- Pneumocystis jirovecii pneumonia detection and treatment
- Hepatitis B Virus Studies
- Clinical Nutrition and Gastroenterology
- Organ Transplantation Techniques and Outcomes
- Herpesvirus Infections and Treatments
- SARS-CoV-2 and COVID-19 Research
- Long-Term Effects of COVID-19
- Diet and metabolism studies
- COVID-19 Clinical Research Studies
- Nutrition and Health in Aging
- Cytomegalovirus and herpesvirus research
- Liver Diseases and Immunity
- Neurological Complications and Syndromes
- Hepatocellular Carcinoma Treatment and Prognosis
Medical University of Warsaw
2018-2024
Background: Metabolic syndrome (MS) constitutes an important source of cardiovascular- and cancer-related morbidity mortality in the general population. Limited information is available on whether these findings can be directly extrapolated to liver recipients. This study aimed investigate impact post-transplant MS present 1 year after transplantation survival rates, risk major cardiovascular events (CVEs), de novo malignancies. Methods: Adult deceased-liver-donor recipients who underwent...
Background: The chronic kidney disease (CKD) population, including transplant recipients (KTRs) and subjects on renal replacement therapy, is particularly vulnerable to unfavorable outcomes from hepatitis C (CHC). Currently, there are oral direct-acting antiviral agents (DAAs) available eradicate the virus with favorable short-term outcomes; however, their long-term effects lacking. aim of study assess efficacy safety DAA therapy in CKD population. Methods: An observational, cohort...
Background: Molnupiravir is approved for the treatment of adult patients with mild to moderate COVID-19. The main goal reduce hospitalization and mortality rate. This study aimed at all-cause death assessment in high risk severe COVID-19 treated molnupiravir. Methods: was a prospective, observational single center study. Non-hospitalized SARS-CoV-2 infection, symptoms onset up 5 days, illness received molnupiravir based on attending physician decisions. Results: In total, 107 were enrolled....
Sarcopenia is characterized by the progressive loss of muscle mass, strength, and function poses a significant health challenge among people with diabetes. Sodium-glucose cotransporter-2 inhibitors (SGLT2is) are backbone type 2 diabetes treatment. The interplay between SGLT2is sarcopenia an area active research inconclusive results. This article presents unexpectedly rapid weight reduction, along physical performance deterioration, in elderly patient diabetes, which led to treatment...
Calcineurin inhibitors constitute a cornerstone of immunosuppressive therapy in kidney transplant recipients. There are two main formulations tacrolimus (Tac) which exhibit prolonged-release mode action: Advagraf® (MR-4) and Envarsus® (LCPT). However, they not bioequivalent. Data comparing both once-daily Tac insufficient.The aim the study was to compare safety efficacy profiles LCPT MR-4 adult recipients.An observational, cohort single-center performed. One hundred fifteen recipients...
Metabolic complications are a recognized health concern in liver transplant recipients that result inferior patient-reported outcomes. Patients with MASH known to be disproportionately affected by metabolic diseases compared other indications for transplantation.
Obesity is a well-documented risk factor for the development of hepatocellular carcinoma (HCC) in general population. The applicability these findings to liver recipients uncertain, and results available data have not been unanimous. objective current study was investigate impact pre-operative body mass index (BMI) on oncological outcomes transplantation due HCC. Methods: This observational retrospective enrolled all patients with histologically confirmed HCC who underwent from deceased...
Obesity and diabetes mellitus epidemics exert a measurable impact on the liver transplant (Ltx) population. This study aimed to investigate metabolic profile of Ltx recipients its association with body fat distribution. Adults who underwent de novo elective cadaveric-donor were eligible. Metabolic syndrome (MS) was diagnosed based adapted International Diabetes Federation, American Heart Association, National Heart, Lung, Blood Institute guidelines. We recruited 100 patients mean age 54...
Chronic hepatitis C (CHC) is prevalent in the hemodialysis-dependent population. Currently, all patients with CHC should be considered for treatment; however, many are still left untreated. Following HCV cure, accurate surveillance mandatory to reduce liver-related mortality and prevent reinfection. We aimed establish management practices barriers elimination dialysis centers Poland. Polish were surveyed via email. The strategies investigated. Representatives of 112 responded, representing...